Investeringsforeningen Nykredit Invest Balance
Investeringsforeningen Nykredit Invest Balance ophæver suspension af udvalgte afdelinger
Investeringsforeningen Nykredit Invest Balance ophæver suspension af udvalgte afdelinger
I forlængelse af tidligere meddelelse d. 22. maj 2025 skal det herved oplyses, at det nu igen er muligt at stille indre værdier i nedenstående afdelinger, hvorfor Nykredit Portefølje Administration A/S har anmodet Nasdaq Copenhagen A/S om, at suspension ophæves.
Ophævelsen gælder nedenstående afdelinger:
| Fund Name | ISIN | Order Book Code |
| Defensiv KL | DK0016188733 | NBIDEKL |
| Moderat KL | DK0016188816 | NBIMOKL |
| Offensiv KL | DK0060441749 | NBIOFKL |
Eventuelle spørgsmål vedrørende denne meddelelse kan rettes til npa.pm@nykredit.dk eller CRH@nykredit.dk
Med venlig hilsen
Nykredit Portefølje Administration A/S
Tage Fabrin-Brasted
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Merus N.V.22.5.2025 23:30:00 CEST | Press release
Merus’ Petosemtamab with Pembrolizumab Interim Data Demonstrates Robust Efficacy and Durability in 1L PD-L1+ r/m HNSCC
Boehringer Ingelheim Limited22.5.2025 23:05:43 CEST | Press release
Boehringer Ingelheim to present early clinical evidence of innate immune modulation and anti-tumor activity via SIRPα blockade in two ongoing trials at ASCO 2025
Avidicure22.5.2025 23:05:00 CEST | Press release
Avidicure to Present Preclinical Data from Lead TROP2-targeting Multifunctional Antibody Program at the 2025 American Society of Clinical Oncology Annual Meeting
Genmab A/S22.5.2025 23:05:00 CEST | Press release
Genmab to Highlight New Data Evaluating Late-Stage Oncology Portfolio at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting
Zymeworks Inc.22.5.2025 23:00:00 CEST | Press release
Zymeworks Announces Presentations Highlighting Breadth of Oncology Portfolio at Upcoming Medical Conferences
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom